E
Elena Ganea-Motan
Publications - 2
Citations - 554
Elena Ganea-Motan is an academic researcher. The author has contributed to research in topics: Cancer & Paracentesis. The author has an hindex of 2, co-authored 2 publications receiving 500 citations.
Papers
More filters
Journal ArticleDOI
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
Markus M. Heiss,Pawel Murawa,Piotr Koralewski,Elzbieta Kutarska,Olena O. Kolesnik,Vladimir V. Ivanchenko,Alexander S. Dudnichenko,Birute Aleknaviciene,Arturas Razbadauskas,Martin Gore,Elena Ganea-Motan,Tudor Ciuleanu,Pauline Wimberger,Alexander Schmittel,Barbara Schmalfeldt,Alexander Burges,Carsten Bokemeyer,Horst Lindhofer,Angelika Lahr,Simon L. Parsons +19 more
TL;DR: Catumaxomab showed a clear clinical benefit in patients with malignant ascites secondary to epithelial cancers, especially gastric cancer, with an acceptable safety profile.
Journal ArticleDOI
XM02, the first biosimilar G-CSF, is safe and effective in reducing the duration of severe neutropenia and incidence of febrile neutropenia in patients with small cell or non-small cell lung cancer receiving platinum-based chemotherapy.
Ulrich Gatzemeier,Tudor Ciuleanu,Mircea Dediu,Elena Ganea-Motan,Heinz Lubenau,Auro Del Giglio +5 more
TL;DR: Treatment with XM02 is beneficial in ameliorating severe neutropenia and febrile neutropania in lung cancer patients receiving myelosuppressive chemotherapy.